113 related articles for article (PubMed ID: 34515462)
1. Chemoproteomics Enabled Discovery of Selective Probes for NuA4 Factor BRD8.
Remillard D; Savage NA; Kedves AT; Paulk J; Chen X; Garcia FJ; Romanowski MJ; Horton PA; Murphy J; Schirle M; Harrington EM; Maxwell MB; Pham HT; Maksimovic I; Thomas JR; Forrester WC
ACS Chem Biol; 2021 Nov; 16(11):2185-2192. PubMed ID: 34515462
[TBL] [Abstract][Full Text] [Related]
2. An Advanced Tool To Interrogate BRD9.
Karim RM; Schönbrunn E
J Med Chem; 2016 May; 59(10):4459-61. PubMed ID: 27120693
[TBL] [Abstract][Full Text] [Related]
3. Bromodomain protein BRD8 regulates cell cycle progression in colorectal cancer cells through a TIP60-independent regulation of the pre-RC complex.
Yamaguchi K; Nakagawa S; Saku A; Isobe Y; Yamaguchi R; Sheridan P; Takane K; Ikenoue T; Zhu C; Miura M; Okawara Y; Nagatoishi S; Kozuka-Hata H; Oyama M; Aikou S; Ahiko Y; Shida D; Tsumoto K; Miyano S; Imoto S; Furukawa Y
iScience; 2023 Apr; 26(4):106563. PubMed ID: 37123243
[TBL] [Abstract][Full Text] [Related]
4. Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands.
Remillard D; Buckley DL; Paulk J; Brien GL; Sonnett M; Seo HS; Dastjerdi S; Wühr M; Dhe-Paganon S; Armstrong SA; Bradner JE
Angew Chem Int Ed Engl; 2017 May; 56(21):5738-5743. PubMed ID: 28418626
[TBL] [Abstract][Full Text] [Related]
5. Research progress of selective small molecule bromodomain-containing protein 9 inhibitors.
Hui M; Jian Z; Peiyuan Z; Zhenwei W; Huibin Z
Future Med Chem; 2018 Apr; 10(8):895-906. PubMed ID: 29620420
[TBL] [Abstract][Full Text] [Related]
6. Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.
Theodoulou NH; Bamborough P; Bannister AJ; Becher I; Bit RA; Che KH; Chung CW; Dittmann A; Drewes G; Drewry DH; Gordon L; Grandi P; Leveridge M; Lindon M; Michon AM; Molnar J; Robson SC; Tomkinson NC; Kouzarides T; Prinjha RK; Humphreys PG
J Med Chem; 2016 Feb; 59(4):1425-39. PubMed ID: 25856009
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor.
Martin LJ; Koegl M; Bader G; Cockcroft XL; Fedorov O; Fiegen D; Gerstberger T; Hofmann MH; Hohmann AF; Kessler D; Knapp S; Knesl P; Kornigg S; Müller S; Nar H; Rogers C; Rumpel K; Schaaf O; Steurer S; Tallant C; Vakoc CR; Zeeb M; Zoephel A; Pearson M; Boehmelt G; McConnell D
J Med Chem; 2016 May; 59(10):4462-75. PubMed ID: 26914985
[TBL] [Abstract][Full Text] [Related]
8. BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors.
Krämer KF; Moreno N; Frühwald MC; Kerl K
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28714904
[TBL] [Abstract][Full Text] [Related]
9. The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9.
Klein DC; Lardo SM; Hainer SJ
Cancer Res Commun; 2024 Jan; 4(1):237-252. PubMed ID: 38126767
[TBL] [Abstract][Full Text] [Related]
10. BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors.
Wang X; Wang S; Troisi EC; Howard TP; Haswell JR; Wolf BK; Hawk WH; Ramos P; Oberlick EM; Tzvetkov EP; Ross A; Vazquez F; Hahn WC; Park PJ; Roberts CWM
Nat Commun; 2019 Apr; 10(1):1881. PubMed ID: 31015438
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis of Inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains.
Karim RM; Chan A; Zhu JY; Schönbrunn E
J Med Chem; 2020 Mar; 63(6):3227-3237. PubMed ID: 32091206
[TBL] [Abstract][Full Text] [Related]
12. The Bromodomain Containing 8 (BRD8) transcriptional network in human lung epithelial cells.
Browne JA; NandyMazumdar M; Paranjapye A; Leir SH; Harris A
Mol Cell Endocrinol; 2021 Mar; 524():111169. PubMed ID: 33476703
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibition.
Ali MM; Naz S; Ashraf S; Knapp S; Ul-Haq Z
Int J Biol Macromol; 2023 Mar; 230():123428. PubMed ID: 36709803
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of imidazo[1,5-a]pyrazin-8(7H)-one derivatives as BRD9 inhibitors.
Zheng P; Zhang J; Ma H; Yuan X; Chen P; Zhou J; Zhang H
Bioorg Med Chem; 2019 Apr; 27(7):1391-1404. PubMed ID: 30824168
[TBL] [Abstract][Full Text] [Related]
15. Application of Atypical Acetyl-lysine Methyl Mimetics in the Development of Selective Inhibitors of the Bromodomain-Containing Protein 7 (BRD7)/Bromodomain-Containing Protein 9 (BRD9) Bromodomains.
Clegg MA; Bamborough P; Chung CW; Craggs PD; Gordon L; Grandi P; Leveridge M; Lindon M; Liwicki GM; Michon AM; Molnar J; Rioja I; Soden PE; Theodoulou NH; Werner T; Tomkinson NCO; Prinjha RK; Humphreys PG
J Med Chem; 2020 Jun; 63(11):5816-5840. PubMed ID: 32410449
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans.
Doyon Y; Selleck W; Lane WS; Tan S; Côté J
Mol Cell Biol; 2004 Mar; 24(5):1884-96. PubMed ID: 14966270
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism study of several inhibitors binding to BRD9 bromodomain based on molecular simulations.
Song LT; Tu J; Liu RR; Zhu M; Meng YJ; Zhai HL
J Biomol Struct Dyn; 2019 Jul; 37(11):2970-2979. PubMed ID: 30058436
[TBL] [Abstract][Full Text] [Related]
18. MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator.
Jiang CY; Ruan Y; Wang XH; Zhao W; Jiang Q; Jing YF; Han BM; Xia SJ; Zhao FJ
Mol Cell Endocrinol; 2016 May; 427():13-20. PubMed ID: 26940039
[TBL] [Abstract][Full Text] [Related]
19. Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8.
Wu T; Chen Y; You Q; Jiang Z; Chen X
Eur J Med Chem; 2024 Mar; 268():116271. PubMed ID: 38401187
[TBL] [Abstract][Full Text] [Related]
20. Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders.
Pierri M; Gazzillo E; Chini MG; Ferraro MG; Piccolo M; Maione F; Irace C; Bifulco G; Bruno I; Terracciano S; Lauro G
Bioorg Chem; 2022 Jan; 118():105480. PubMed ID: 34823196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
